It was found that there was a positive correlation between CD74 and the ImmuneScore in most cancers (Fig. 7A), with strong correlations seen in the top six tumor types, as seen in Fig. S10A. Differential expression of CD74 was then investigated in different immune subtypes using TISDB. Here, CD74 is linked to cancer.